Evidence map›Paper›PMID 39409030›Full record

ArticleInternational journal of molecular sciences2024

Understanding the Dosage-Dependent Role of

María Rojo-Pardillo, Ludivine Godefroid, Geneviève Dom, Anne Lefort, Frederick Libert, Bernard Robaye, Carine Maenhaut

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Cells · 2025
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

María Rojo-PardilloIRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Ludivine GodefroidIRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Geneviève DomIRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Anne LefortIRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Frederick LibertIRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Bernard RobayeIRIBHM J. E. Dumont, Université Libre de Bruxelles, Campus Charleroi, 6041 Charleroi, Belgium.
Carine MaenhautIRIBHM J. E. Dumont, Université Libre de Bruxelles, 1070 Brussels, Belgium.

Funding

Fondation David et Alice Van Buuren N/AFondation Héger-Masson N/AFondation Jaumotte-Demoulin N/AFund for Scientific Research FRIA grant (FC36079)Fund for Scientific Research - Research credit CDR J.0123.23Jean Hoguet Foundation N/AKing Baudouin Foundation Fund Doctor J.P. Naets, grant 2023-J1813300-233020
6 · The paper itself

Abstract

Tumors originating from thyroid follicular cells are the most common endocrine tumors, with rising incidence. Despite a generally good prognosis, up to 20% of patients experience recurrence and persistence, highlighting the need to identify the underlying molecular mechanisms.

Indexed as

ApoptosisCell ProliferationDEAD-box RNA HelicasesRibonuclease IIIThyroid NeoplasmsCarcinogenesisCell CycleCell Line, TumorCell MovementGene DosageGene Expression Regulation, NeoplasticHumansThyroid Cancer, PapillaryDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIIDicer1microRNAspapillary thyroid carcinomathyroidthyroid cancer

Identifiers

PMID39409030
PMCPMC11476720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.